The Diagnosis of Clotting Factor Deficiencies
Baldwin, R.D.
Journal of the Medical Society of New Jersey 61: 369-372
1964
ISSN/ISBN: 0025-7524 PMID: 14180708 Document Number: 10028
Excessive blood loss into an unusual site or without clear-cut cause should be investigated. Troublesome nose bleeds, easy bruising, heavy and prolonged menstrual flow are clues which should initiate an investigation of the patient's hemostatic capacities.
Document emailed within 1 workday
Related Documents
Hemker, H.C.; Kop, J.; Willems, G.M. 1979: Kinetic aspects of the interaction of blood clotting enzymes. VIII. the relation between clotting time and clotting velocity Thrombosis and Haemostasis 41(2): 309-313Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647
Mariani, G.; Di Nucci, G.D.; Arcieri, P. 1994: Immunopurified clotting factor concentrates Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S61-S65
Thomas, D.P. 1995: Clotting factor concentrated--whither purity? Thrombosis and Haemostasis 74(6): 1604-1606
Kalashnikova, L.A.; Berkovskiĭ, A.L.; Dobrynina, L.A.; Sergeeva, E.V.; Kozlov, A.A.; Aleksandrova, E.N.; Nasonov, E.L. 2003: Clotting factor VIIi in Sneddon syndrome Klinicheskaia Meditsina 81(9): 42-45
Kitchen, S.; Preston, F.E. 1993: Factor VIi clotting assays: influence of thromboplastin Thrombosis and Haemostasis 70(4): 720
Rubinstein, D.B. 1995: Virus infection and clotting factor concentrates Lancet 345(8959): 1248
Westhoff, C.L.; Eisenberger, A.; Tang, R.; Cremers, S.; Grossman, L.V.; Pike, M.C. 2016: Clotting factor changes during the first cycle of oral contraceptive use Contraception 93(1): 70-76
Gomperts, E.D.; Jordan, S.; Berg, D.; Sakai, R.; Boylen, L. 1981: Circulating immune complexes pre and post clotting factor infusion in hemophilia Thrombosis and Haemostasis 46(4): 694-698
Beck, E.A.; Furlan, M. 1979: Structure and function of clotting factor VIII: the results of fundamental research Therapeutische Umschau. Revue Therapeutique 36(4): 294-300
Bairova, T.A.; Gommellya, M.V.; Dolgich, V.V.; Philippov, E.S.; Kolesnikova, L.I. 2016: Polymorphism (353)R>Q of Gene of Blood Clotting Factor FVIi and Plasma Hemostasis Genetika 52(2): 242-248
Han, P.; Fung, K.P.; Rahdakrishnan, U. 1991: Lack of agreement of chromogenic and clotting assays for factor X and protein C in warfarinised plasma Thrombosis and Haemostasis 65(4): 360-363
Tham, C.J.; Trew, M.; Brager, N. 1999: Abnormal clotting and production of factor VIIi inhibitor in a patient treated with venlafaxine Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(9): 923-924
Reed, R.L.; Bracey, A.W.; Hudson, J.D.; Miller, T.A.; Fischer, R.P. 1990: Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels Circulatory Shock 32(2): 141-152
Mäkinen, T.; Tötterman, T.H.; Gordin, A.; Weber, T.H. 1977: Migration inhibition factor and the blood clotting system: effects of defibrination, heparin and thrombin Clinical and Experimental Immunology 29(1): 181-186
Lutze, G.; Canzler, E.; Presser, H.J. 1989: Spontaneous post-partum inhibitor to factor VIIi clotting anti- gen--a cause of life-threatening hemorrhage Zentralblatt für Gynakologie 111(3): 167-172
Lerner, R.G.; Goldstein, R.; Cummings, G. 1977: Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil production of tissue factor Thrombosis Research 11(2): 253-261
Glueck, C.J.; Crawford, A.; Roy, D.; Freiberg, R.; Glueck, H.; Stroop, D. 1996: Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease Journal of Bone and Joint Surgery. American Volume 78(1): 3-13
Herndon, W.A. 1997: Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease Journal of Bone and Joint Surgery. American Volume 79(7): 1114-1115
Köller, U.; Majdic, O.; Liszka, K.; Stockinger, H.; Pabinger-Fasching, I.; Lechner, K.; Knapp, W. 1985: Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens Clinical and Experimental Immunology 59(3): 613-621